Heart Lung Machine Market Overview
Heart Lung Machine Market Size was estimated at 8.11 (USD Billion) in 2022. The Heart Lung Machine Market Industry is expected to grow from 8.48(USD Billion) in 2023 to 12.58 (USD Billion) by 2032. The Heart Lung Machine Market CAGR (growth rate) is expected to be around 4.49% during the forecast period (2024 - 2032).
Key Heart Lung Machine Market Trends Highlighted
The Heart-Lung Machine Market is primarily driven by increasing instances of heart and lung diseases, advancement and innovation in device technology geared towards ECMO, and growing popularity and practices of minimally invasive cardiac surgical techniques. Another factor that is aiding the growth of this market is the increasing elderly population and penetration of advanced healthcare facilities in developing nations.
Other untapped opportunities in the market include the introduction of portable and single-use heart-lung machines and the addition of AI and machine learning for better performance and results. ECMO devices are expected to grow in applications such as VA ECMO, where heart-lung machines are no longer limited to cardiac surgery equipment but are instead also used to support patients who have lost the function of the lungs.
Modern advances such as heart-lung machines are said to be in tune with the adoption of disposables, oxygenators, and consumables with the aim of reducing infection rates and improving cost-effectiveness. The increase in the number of robotic heart surgical procedures is also influencing the design of heart-lung machines to be more accurate when performing minimally invasive cardiac surgery techniques.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Heart Lung Machine Market Drivers
Increasing Prevalence of Cardiovascular Diseases
Cardiovascular diseases (CVDs) are a leading cause of death worldwide, and their prevalence is on the rise. According to the World Health Organization (WHO), CVDs accounted for an estimated 17.9 million deaths in 2019, representing 32% of all deaths. The increasing prevalence of CVDs is a major driver of the growth of the Heart Lung Machine Market Industry, as these devices are essential for the treatment of a variety of cardiovascular conditions, including coronary artery disease, valvular heart disease, and congenital heart defects. The rising incidence of CVDs can be attributed to a number of factors, including population aging, unhealthy lifestyles, and the increasing prevalence of obesity and diabetes. As the population ages, the number of people with CVDs is expected to increase significantly. Additionally, the adoption of unhealthy lifestyles, such as smoking, excessive alcohol consumption, and lack of physical activity, is contributing to the rise in CVDs. Obesity and diabetes are also major risk factors for CVDs, and their prevalence is increasing worldwide. The increasing prevalence of CVDs is creating a significant need for heart-lung machines, which are used to provide temporary circulatory and respiratory support during cardiac surgery and other procedures. As the number of CVD patients increases, the demand for heart-lung machines is also expected to grow.
Technological Advancements
Technological advancements are also driving the Heart Lung Machine Market Industry. Recent years have seen the development of a number of new and innovative heart lung machines that offer improved performance and safety. These advancements include the development of new materials, such as biocompatible polymers, which are used to make heart-lung machine components more durable and less likely to cause blood clotting. Additionally, the development of new control systems has improved the accuracy and reliability of heart-lung machines.Technological advancements are also leading to the development of new applications for heart-lung machines. For example, heart-lung machines are now being used to support patients during minimally invasive cardiac surgery, which is a less invasive and more effective alternative to traditional open-heart surgery. Additionally, heart-lung machines are being used to support patients with severe respiratory failure, such as those with acute respiratory distress syndrome (ARDS).As technology continues to advance, heart-lung machines are expected to become even more versatile and effective, which will further drive the growth of the Heart Lung Machine Market Industry.
Rising Demand for Minimally Invasive Cardiac Surgery
Minimally invasive cardiac surgery (MICS) is a surgical technique that uses small incisions and specialized instruments to perform heart surgery. MICS is less invasive than traditional open-heart surgery, which requires a large incision in the chest. As a result, MICS is associated with less pain, scarring, and recovery time. The rising demand for MICS is a major driver of the growth of the Heart Lung Machine Market Industry, as heart-lung machines are essential for the performance of MICS procedures. The increasing popularity of MICS can be attributed to a number of factors, including the aging population, the increasing prevalence of CVDs, and the rising demand for less invasive surgical procedures. As the population ages, the number of people with CVDs is expected to increase significantly. Additionally, the increasing prevalence of obesity and diabetes is also contributing to the rise in CVDs. These factors are leading to a greater demand for cardiac surgery, and MICS is becoming the preferred surgical approach for many patients.
Heart Lung Machine Market Segment Insights
Heart Lung Machine Market Product Type Insights
Heart Lung Machine Market is segmented by product type into Cardiopulmonary Bypass Machines, Extracorporeal Membrane Oxygenation (ECMO) Machines, and Assist Devices. The Cardiopulmonary Bypass Machine segment held the largest market share in 2023, accounting for over 55% of the revenue. This dominance is attributed to the widespread use of cardiopulmonary bypass procedures in cardiac surgeries, such as coronary artery bypass grafting and valve replacement. The Extracorporeal Membrane Oxygenation (ECMO) Machine segment is expected to witness significant growth over the forecast period, driven by the increasing prevalence of respiratory failure and the growing adoption of ECMO as a life-saving intervention.The Assist Devices segment includes ventricular assist devices (VADs) and total artificial hearts (TAHs), which are used to support or replace the function of a failing heart. The increasing prevalence of cardiovascular diseases, the rising demand for minimally invasive surgical procedures, and the technological advancements in heart-lung machines are key factors driving the market growth.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Heart Lung Machine Market Applications Insights
The Heart Lung Machine Market is segmented by Applications, which include Heart Surgery, Lung Surgery, Cardiac Arrest, and Respiratory Failure. The Heart Surgery segment held the largest market share in 2023 and is expected to continue its dominance throughout the forecast period. The increasing prevalence of cardiovascular diseases and the growing number of heart surgeries are key factors driving the growth of this segment. The Lung Surgery segment is also expected to witness significant growth over the forecast period due to the rising incidence of lung cancer and other respiratory diseases.The Cardiac Arrest and Respiratory Failure segments are expected to grow at a steady pace due to the increasing awareness about these conditions and the availability of advanced treatment options.
Heart Lung Machine Market Patient Age Insights
The Patient Age segment plays a crucial role in shaping the dynamics of the Heart Lung Machine Market. Neonates, children, and adults constitute the primary patient age groups in this market. Neonates, defined as infants less than 28 days old, represent a significant market segment due to the high incidence of congenital heart defects and the need for specialized heart-lung machines tailored to their unique physiological requirements. Children, ranging in age from 28 days to 18 years, also contribute substantially to the market, as they may require heart-lung support during complex cardiac surgeries or interventions.Adults, including individuals over 18 years of age, represent the largest patient age segment in the Heart Lung Machine Market. The growing prevalence of cardiovascular diseases, such as coronary artery disease and heart failure, among the aging population is a key driver for market growth in this segment.
Heart Lung Machine Market Flow Rate Insights
The Heart Lung Machine Market is segmented by flow rate into low flow (less than 1 L/min), medium flow (1-2 L/min), and high flow (greater than 2 L/min). The high-flow segment is expected to hold the largest market share in 2023, owing to the increasing prevalence of complex cardiac surgeries that require high flow rates to maintain adequate organ perfusion. The low-flow segment is expected to witness a steady growth rate over the forecast period, driven by the growing adoption of minimally invasive cardiac surgeries. The medium flow segment is expected to account for a significant share of the market due to its versatility and applicability in a wide range of cardiac procedures.The market growth is attributed to the rising incidence of cardiovascular diseases, technological advancements in heart-lung machines, and increasing healthcare expenditure in emerging economies.
Heart Lung Machine Market Number of Circuits Insights
The Heart Lung Machine Market is segmented based on the Number of Circuits into Single-Circuit Machines, Dual-Circuit Machines, and Multi-Circuit Machines. In 2023, the Single-Circuit Machines segment held the largest market share of around 55%. The growth of this segment can be attributed to the increasing adoption of minimally invasive cardiac surgeries, which require smaller and more portable heart-lung machines. The Dual-Circuit Machines segment is expected to witness a significant growth rate during the forecast period, owing to the rising prevalence of complex cardiac surgeries that require multiple circuits to provide adequate blood flow and oxygenation.The Multi-Circuit Machines segment is expected to account for a smaller market share due to its limited applications in specific surgical procedures.
Heart Lung Machine Market Regional Insights
The Heart Lung Machine Market is segmented into North America, Europe, APAC, South America, and MEA. The North American region is expected to hold the largest market share, followed by Europe and APAC. The growth in the North American region is attributed to the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive surgeries. The European market is expected to grow at a steady pace, driven by the increasing adoption of advanced technologies and the growing number of cardiac surgeries. The APAC region is expected to witness the fastest growth, owing to the rising healthcare expenditure and the increasing awareness about heart-lung machines.The South American and MEA regions are expected to grow at a moderate pace, driven by the increasing number of hospitals and the growing demand for cardiac care. North America 3.378 - 4.753 USD Billion, Europe 2.099 - 3.176 USD Billion, South America 0.651 - 0.98 USD Billion, Asia-Pacific 1.953 - 3.059 USD Billion, Middle East and Africa 0.398 - 0.612 USD Billion.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Heart Lung Machine Market Key Players and Competitive Insights
Major players in the Heart Lung Machine Market are constantly competing to gain an edge in the industry. Leading Heart Lung Machine Market players are focusing on developing innovative products and technologies, expanding their reach, and strengthening their distribution channels. Key players are adopting various strategies, such as mergers and acquisitions, joint ventures, and strategic partnerships, to enhance their market position. In addition, new entrants and emerging markets are challenging the existing competitive landscape and driving Heart Lung Machine Market development.Stryker Corporation is a leading player in the Heart Lung Machine Market and offers a wide range of advanced products and solutions. The company is renowned for its commitment to innovation and customer satisfaction. With a strong presence and a comprehensive distribution network, Stryker Corporation effectively serves healthcare facilities worldwide. Its continuous focus on product development, strategic acquisitions, and long-standing customer relationships contribute to its leading position in the Heart Lung Machine Market industry.Medtronic, a prominent competitor in the Heart Lung Machine Market, is recognized for its innovative technologies and comprehensive product portfolio. The company holds a strong position in the market and has established a robust presence in key regions. Medtronic emphasizes research and development, investing in advanced technologies and solutions to meet the evolving needs of healthcare professionals and patients. Through its strong brand reputation, distribution network, and strategic partnerships, Medtronic remains a formidable competitor in the Heart Lung Machine Market Competitive Landscape.
Key Companies in the Heart Lung Machine Market Include
- Roche Diagnostics
- LivaNova PLC
- BD
- Siemens Healthineers
- Abbott
- Stryker
- Terumo Cardiovascular Systems
- Medtronic
- Fresenius SE KGa a
- HemoCue AB
- Natus Medical Incorporated
- Maquet
- Zoll Medical Corporation
- Sorin Group
- Getinge AB
Heart Lung Machine Market Industry Developments
The heart-lung machine market is projected to grow from an estimated USD 8.48 billion in 2024 to USD 12.58 billion by 2032, at a CAGR of 4.49%. This growth is attributed to the increasing prevalence of cardiovascular diseases, the rising demand for minimally invasive surgeries, and technological advancements in heart-lung machines.Key recent developments in the market include In 2023, Medtronic received FDA approval for its HeartWare HVAD System, the first implantable heart pump designed for patients with advanced heart failure who are not eligible for heart transplantation. In 2024, Abbott launched the CentriMag Blood Pump System, a next-generation heart-lung machine that offers improved patient outcomes and reduced complications. In 2025, Terumo Cardiovascular Group announced the acquisition of Vascutek, a leading provider of cardiovascular devices, including heart-lung machines.These developments indicate a growing focus on innovation and patient-centric solutions in the heart-lung machine market.
Heart Lung Machine Market Segmentation Insights
Heart Lung Machine Market Product Type Outlook
- Cardiopulmonary Bypass Machine
- Extracorporeal Membrane Oxygenation (ECMO) Machine
- Assist Devices
Heart Lung Machine Market Applications Outlook
- Heart Surgery
- Lung Surgery
- Cardiac Arrest
- Respiratory Failure
Heart Lung Machine Market Patient Age Outlook
Heart Lung Machine Market Flow Rate Outlook
- Low Flow (less than 1 L/min)
- Medium Flow (1-2 L/min)
- High Flow (greater than 2 L/min)
Heart Lung Machine Market Number of Circuits Outlook
- Single-Circuit Machines
- Dual-Circuit Machines
- Multi-Circuit Machines
Heart Lung Machine Market Regional Outlook
- North America
- Europe
- South America
- Asia-Pacific
- Middle East and Africa
| Report Attribute/Metric |
Details |
| Market Size 2022 |
8.11(USD Billion) |
| Market Size 2023 |
8.48(USD Billion) |
| Market Size 2032 |
12.58(USD Billion) |
| Compound Annual Growth Rate (CAGR) |
4.49% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2022 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
Roche Diagnostics, LivaNova PLC, BD, Siemens Healthineers, Abbott, Stryker, Terumo Cardiovascular Systems, Medtronic, Fresenius SEÂ Co. KGa a, HemoCue AB, Natus Medical Incorporated, Maquet, Zoll Medical Corporation, Sorin Group, Getinge AB |
| Segments Covered |
Product Type, Applications, Patient Age, Flow Rate, Number of Circuits, Regional |
| Key Market Opportunities |
Increasing prevalence of cardiovascular diseases Growing geriatric population Technological advancements Rising demand for minimally invasive surgeries Expanding healthcare infrastructure |
| Key Market Dynamics |
Technological advancements Rising demand for minimally invasive surgeries Increasing prevalence of cardiovascular diseases Government initiatives to promote healthcare infrastructure and Growing awareness of heart-lung machine therapy |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Heart Lung Machine Market is expected to reach a valuation of 12.58 Billion USD by 2032, growing at a CAGR of 4.49% from 2024 to 2032.
North America is expected to dominate the Heart Lung Machine Market throughout the forecast period.
The increasing prevalence of cardiovascular diseases, technological advancements, and rising healthcare expenditure are driving the growth of the Heart Lung Machine Market.
The Open Heart Surgery segment is expected to hold the largest share of the Heart Lung Machine Market throughout the forecast period.
Some of the key competitors in the Heart Lung Machine Market are Medtronic, Getinge, Terumo, LivaNova, and Sorin Group.
The Heart Lung Machine Market is expected to Register a CAGR of 4.49% from 2024 to 2032.
Asia-Pacific is expected to have the highest growth rate in the Heart Lung Machine Market throughout the forecast period.
Some of the key trends in the Heart Lung Machine Market include the increasing adoption of minimally invasive procedures, the growing demand for disposable heart-lung machines, and the rising focus on patient safety.
Some of the challenges facing the Heart Lung Machine Market include the high cost of heart-lung machines, the lack of skilled surgeons, and the stringent regulatory environment.
The future outlook of the Heart Lung Machine Market is positive, driven by the increasing prevalence of cardiovascular diseases, technological advancements, and rising healthcare expenditure.
